Welltower Inc.

DB:HCW Stock Report

Market Cap: €146.7b

Welltower Valuation

Is HCW undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of HCW when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: HCW (€203.4) is trading below our estimate of future cash flow value (€205.15)

Significantly Below Future Cash Flow Value: HCW is trading below future cash flow value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for HCW?

Key metric: As HCW is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for HCW. This is calculated by dividing HCW's market cap by their current earnings.
What is HCW's PE Ratio?
PE Ratio109.5x
EarningsUS$1.55b
Market CapUS$169.75b

Price to Earnings Ratio vs Peers

How does HCW's PE Ratio compare to its peers?

The above table shows the PE ratio for HCW vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average89.6x
VTR Ventas
178.7x28.77%US$46.6b
OHI Omega Healthcare Investors
16.7x-8.25%US$14.6b
DOC Healthpeak Properties
59.1x-30.13%US$14.6b
AHR American Healthcare REIT
103.8x27.95%US$12.5b
HCW Welltower
109.5x16.84%€169.7b

Price-To-Earnings vs Peers: HCW is expensive based on its Price-To-Earnings Ratio (109.5x) compared to the peer average (89.6x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does HCW's PE Ratio compare vs other companies in the Global Health Care REITs Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
HCW 109.5xIndustry Avg. 17.2xNo. of Companies7PE01020304050+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: HCW is expensive based on its Price-To-Earnings Ratio (109.5x) compared to the Global Health Care REITs industry average (17.2x).

Price to Earnings Ratio vs Fair Ratio

What is HCW's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HCW PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio109.5x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate HCW's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst HCW forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€203.40
€221.77
+9.03%
8.77%€253.46€166.66n/a22
Aug ’27€204.50
€218.81
+7.00%
8.61%€242.73€166.44n/a22
Jul ’27€202.10
€209.18
+3.50%
7.27%€243.46€168.75n/a21
Jun ’27€169.70
€203.63
+19.99%
7.31%€238.25€165.14n/a20
May ’27€186.05
€197.41
+6.11%
6.38%€221.86€163.83n/a20
Apr ’27€171.85
€199.12
+15.87%
7.10%€225.78€159.79n/a20
Mar ’27€175.15
€191.81
+9.51%
7.87%€219.93€155.65n/a20
Feb ’27€158.65
€179.01
+12.83%
8.71%€217.28€143.74n/a20
Jan ’27€160.10
€176.90
+10.49%
10.21%€220.82€137.59n/a21
Dec ’26€175.70
€178.64
+1.67%
9.07%€223.96€148.16n/a21
Nov ’26€156.25
€166.11
+6.31%
9.87%€213.41€137.07n/a21
Oct ’26€152.75
€158.68
+3.88%
8.96%€204.43€134.58n/a21
Sep ’26€143.15
€152.58
+6.59%
10.84%€205.18€124.82n/a19
Aug ’26€143.40
€150.18
+4.73%
11.16%€210.19€126.99€204.5019
Jul ’26€128.35
€143.82
+12.05%
11.30%€205.03€123.87€202.1020
Jun ’26€135.60
€147.97
+9.13%
11.32%€211.39€127.72€169.7020
May ’26€134.05
€146.23
+9.09%
12.24%€214.34€118.68€186.0520
Apr ’26€142.70
€152.66
+6.98%
13.64%€223.68€117.39€171.8519
Mar ’26€147.35
€152.34
+3.39%
14.65%€233.34€122.45€175.1519
Feb ’26€131.45
€143.23
+8.96%
13.26%€213.20€120.59€158.6519
Jan ’26€118.85
€139.90
+17.71%
10.23%€183.45€118.76€160.1019
Dec ’25€130.90
€131.12
+0.16%
11.95%€179.84€108.85€175.7019
Nov ’25€122.55
€122.02
-0.43%
13.50%€175.71€102.65€156.2519
Oct ’25€115.45
€112.45
-2.60%
8.96%€133.70€96.66€152.7519
Sep ’25€109.10
€109.24
+0.13%
7.39%€123.96€95.91€143.1519
Aug ’25€103.60
€102.65
-0.92%
6.84%€119.33€92.50€143.4019
€220.66
Fair Value
7.8% undervalued intrinsic discount
22
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/15 14:08
End of Day Share Price 2026/08/14 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Welltower Inc. is covered by 48 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Amanda SweitzerBaird
David RodgersBaird
Bryan SekinoBarclays